HR 6238 · 116th Congress · Taxation

Cameron’s Law

Introduced 2020-03-12· Sponsored by Rep. Gottheimer, Josh [D-NJ-5]· House

Bill Progress

Introduced
2
Committee
3
House Vote
4
Senate
5
Enacted
Latest: Referred to the Committee on Ways and Means, and in addition to the Committee on Energy and Commerce, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.(2020-03-12)

Plain Language Summary

[AI summary unavailable — showing source text] Cameron's Law This bill increases the rate of the tax credit for clinical testing expenses for rare diseases or conditions from 25% to 50% (orphan drug tax credit). The bill also requires the Centers for Disease Control and Prevention to complete a study and report on enhancing and expanding the infrastructure to track the epidemiology of rare diseases or conditions.…

Summarized by Claude AI · Non-partisan · For informational purposes only

Cosponsors (1)

1 Republican